✅ This partnership allows Retro to manufacture therapies at a cost-efficient scale, accelerating their transition to clinical trials and commercialization.
💡 Multiply Labs’ robotic systems provide flexibility and can operate market-leading instruments from different vendors, reducing regulatory barriers.
Introduction:
Multiply Labs and Retro Biosciences have announced a partnership to automate Retro’s approach to target the cellular drivers of aging. This collaboration aims to expedite the development and delivery of life-changing therapies for age-related diseases.
- Multiply Labs and Retro Biosciences have signed an agreement valued at up to $85 million to automate Retro’s approach to address age-related diseases.
- Multiply Labs’ robotic system will support Retro’s efforts to manufacture therapies at a cost-efficient scale, expediting the transition from process development to clinical trials and commercialization.
- Multiply Labs’ modular robotic structure will help enable Retro to bring its unique cell therapies to patients by leveraging cutting-edge robotic technology.
- The collaboration focuses on robotic systems that can operate market-leading instruments from different vendors, offering faster automation timelines and fewer regulatory barriers.
- This partnership signifies a significant step forward in harnessing robotic technology to improve patient access to life-saving therapies and extend human longevity.
Conclusion:
The partnership between Multiply Labs and Retro Biosciences will revolutionize the manufacturing process for age-related disease therapies. By automating Retro’s approach, this collaboration will expedite the development and commercialization of life-changing therapies, benefiting patients worldwide. The use of cutting-edge robotic technology and a modular structure will facilitate the delivery of unique cell therapies, offering faster automation timelines and addressing regulatory barriers. This collaboration represents a significant advancement in the field of cell therapy manufacturing and underscores the commitment to extending human longevity and saving lives.
